Vertex Pharmaceuticals (VRTX) Stock Price, Quote, News & History | Benzinga

Vertex Pharmaceuticals Inc (VRTX) Stock Price, Quote, News & History

VRTXNASDAQ

Trade with Public

Trade with Public

$451.05

-2.01-0.44%

Last update: May 14, 10:02 AM

OverviewNews Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

$453.64

Close

-

Volume / Avg.

72.72K / 1.31M

Day Range

$447.36 - $453.83

52 Wk Range

362.50 - 507.92

Market Cap

$114.48B

P/E Ratio

26.89

Dividend Yield

-

Exchange

NASDAQ

RSI

61

Short Interest

1.86%

Days to Cover

4.31

Recent Vertex Pharmaceuticals Inc News

These Analysts Revise Their Forecasts On Vertex Pharmaceuticals After Q1 Earnings

Vertex Pharmaceuticals Inc reported mixed financial results for Q1, with revenue of $2.99B and adjusted EPS of $4.47. CEO confident in future growth and value creation. Stock fell 2.7% and analysts revised price targets. Considering buying VRTX? Analysts have Outperform ratings and lowered price targets.

Avi Kapoor

Vertex Pharmaceuticals Posts Mixed Q1; Investors Focus On Non-CF Pipeline For Growth

Vertex Pharma posts revenue beat but misses EPS expectations. CF franchise remains strong, says Needham analyst.

Priya Nigam

Vertex Pharmaceuticals Reports Mixed Q1 Results

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) reports financial results for the first quarter after the market close on Monday.

Adam Eckert

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

4.24B

Investing Cash Flow (TTM)

-1.32B

Financing Cash Flow (TTM)

-2.12B

Free Cash Flow (TTM)

3.71B

Capital Expenditure (TTM)

-530.30M

Net Change in Cash (TTM)

799.40M

Analyst Trends and Forecast

5

Feb

8

Mar

1

Apr

4

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$109.73B

PE Ratio (TTM)

26.89

PE Ratio (FWD)

23.81

PEG Ratio (TTM)

1.70

PS Ratio (TTM)

9.54

PB Ratio (TTM)

5.94

Earnings Yield % (TTM)

3.72%

Earnings Yield % (FWD)

4.20%

EV / EBITDA (TTM)

22.03

Price / EBITDA (TTM)

23.39

Price / Free Cash Flow (TTM)

31.41

Book Value / Share

$76.29

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$5.49B

Debt to Equity

0.10

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$453.64

Close

-

Volume / Avg.

72.72K / 1.31M

Day Range

$447.36 - $453.83

52 Wk Range

362.50 - 507.92

Market Cap

$114.48B

P/E Ratio

26.89

Dividend Yield

-

Exchange

NASDAQ

RSI

61

Short Interest

1.86%

Days to Cover

4.31

About

Sector

Health Care

Industry

Biotechnology

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, whe...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Vertex Pharmaceuticals (VRTX) stock?

A

You can purchase shares of Vertex Pharmaceuticals (NASDAQ:VRTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Vertex Pharmaceuticals (VRTX) competitors?

A

There are no as such competitors for Vertex Pharmaceuticals.

Q

What is the forecast, or price target, for Vertex Pharmaceuticals (VRTX) stock?

A

Vertex Pharmaceuticals has a consensus price target of $538.83.

Q

What is the current price for Vertex Pharmaceuticals (VRTX)?

A

The stock price for Vertex Pharmaceuticals (NASDAQ: VRTX) is $451.05 last updated May 14, 2026 at 10:02 AM EDT.

Q

Does Vertex Pharmaceuticals (VRTX) pay a dividend?

A

There are no upcoming dividends for Vertex Pharmaceuticals.

Q

When is Vertex Pharmaceuticals (NASDAQ:VRTX) reporting earnings?

A

Vertex Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Vertex Pharmaceuticals (VRTX) going to split?

A

There is no upcoming split for Vertex Pharmaceuticals.

Q

What sector and industry does Vertex Pharmaceuticals (VRTX) operate in?

A

Vertex Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.